IN2014MN01759A - - Google Patents

Info

Publication number
IN2014MN01759A
IN2014MN01759A IN1759MUN2014A IN2014MN01759A IN 2014MN01759 A IN2014MN01759 A IN 2014MN01759A IN 1759MUN2014 A IN1759MUN2014 A IN 1759MUN2014A IN 2014MN01759 A IN2014MN01759 A IN 2014MN01759A
Authority
IN
India
Prior art keywords
protein
relates
renal
syndecan
sparc
Prior art date
Application number
Inventor
Joseph Anderberg
Jeff Gray
Paul Mcpherson
Kevin Nakamura
James Patrick Kampf
Original Assignee
Astute Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astute Medical Inc filed Critical Astute Medical Inc
Publication of IN2014MN01759A publication Critical patent/IN2014MN01759A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1601—Control or regulation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0413—Blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/75—General characteristics of the apparatus with filters
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The present invention relates to methods and compositions for monitoring diagnosis prognosis and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular the invention relates to using a one or more assays configured to detect a kidney injury marker selected from the group consisting of SPARC Follistatin related protein 1 Tumor necrosis factor receptor superfamily member 21 Growth arrest specific protein 1 MHC class I polypeptide related sequence A Syndecan 1 and WNTl inducible signaling pathway protein 1 as diagnostic and prognostic biomarkers in renal injuries.
IN1759MUN2014 2012-02-27 2013-02-27 IN2014MN01759A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261603906P 2012-02-27 2012-02-27
US201261603912P 2012-02-27 2012-02-27
PCT/US2013/028000 WO2013130591A1 (en) 2012-02-27 2013-02-27 Methods and compositions for diagnosis and prognosis of renal injury and renal failure

Publications (1)

Publication Number Publication Date
IN2014MN01759A true IN2014MN01759A (en) 2015-07-03

Family

ID=49083233

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1759MUN2014 IN2014MN01759A (en) 2012-02-27 2013-02-27

Country Status (9)

Country Link
US (1) US20150010929A1 (en)
EP (1) EP2820146A4 (en)
JP (1) JP2015508181A (en)
CN (1) CN104379758A (en)
AU (1) AU2013226181A1 (en)
CA (1) CA2865559A1 (en)
HK (1) HK1204339A1 (en)
IN (1) IN2014MN01759A (en)
WO (1) WO2013130591A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140363834A1 (en) * 2012-01-28 2014-12-11 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US11143659B2 (en) 2015-01-27 2021-10-12 Arterez, Inc. Biomarkers of vascular disease
CN107709993A (en) * 2015-06-11 2018-02-16 阿斯图特医药公司 Method and composition for diagnosis and the prognosis of injury of kidney and kidney failure

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003075016A1 (en) * 2002-03-07 2003-09-12 Cambridge University Technical Services Limited (Cuts) Scd fingerprints
US20050130193A1 (en) * 2003-09-10 2005-06-16 Luxon Bruce A. Methods for detecting, diagnosing and treating human renal cell carcinoma
FR2872579B1 (en) * 2004-06-30 2006-11-24 Pasteur Institut DETECTION OF TUBERCULOSIS AND MYCOBACTERIUM TUBERCULOSIS INFECTION USING HBHA
US20090178145A1 (en) * 2005-05-11 2009-07-09 The Procter & Gamble Company Methods and targets for identifying compounds for regulating angiogenesis
WO2007106781A2 (en) * 2006-03-10 2007-09-20 University Of Rochester Ecg-based differentiation of lqt1 and lqt2 mutation
JP2012506537A (en) * 2008-10-21 2012-03-15 アスチュート メディカル，インコーポレイテッド Methods and compositions for diagnosis and prognosis of renal injury and renal failure
JP2012517594A (en) * 2009-02-06 2012-08-02 アスチュート メディカル，インコーポレイテッド Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US20120183543A1 (en) * 2009-05-08 2012-07-19 Novartis Ag Diagnostic biomarkers for fibrotic disorders
WO2013096740A1 (en) * 2011-12-21 2013-06-27 Alere San Diego Inc. Methods and compositions for assigning likelihood of chronic kidney disease progression

Also Published As

Publication number Publication date
WO2013130591A1 (en) 2013-09-06
CA2865559A1 (en) 2013-09-06
AU2013226181A1 (en) 2014-09-18
JP2015508181A (en) 2015-03-16
EP2820146A4 (en) 2015-12-16
US20150010929A1 (en) 2015-01-08
CN104379758A (en) 2015-02-25
EP2820146A1 (en) 2015-01-07
HK1204339A1 (en) 2015-11-13

Similar Documents

Publication Publication Date Title
MX366653B (en) METHODS and COMPOSITIONS FOR DIAGNOSIS and PROGNOSIS OF RENAL INJURY and RENAL FAILURE.
EP3070474A3 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
IN2014MN00377A (en)
MX2011008323A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure.
MX341926B (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure.
NZ619883A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP2767833A3 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
MX2014000283A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure.
EP2585827A4 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP2813848A3 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
MX336280B (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure.
EA201790696A1 (en) METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PREDICTION OF KIDNEY DAMAGE AND RENAL FAILURE
MX2019008260A (en) Methods and compositions for evaluation and treatment of renal injury and renal failure based on c-c motif chemokine ligand 14 measurement.
EP2585826A4 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ608316A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
BR112013021056A2 (en) monoclonal antibody, hybridoma cell line, diagnostic kit, methods for producing a monoclonal antibody and binding agent, purified amino acid sequence binding agent, method for obtaining a coding nucleic acid sequence, antibody molecule encoding isolated nucleic acid, vector, isolated host cell, fusion protein, screening method for the presence of a disease, a condition, methods of diagnosing an individual, prognosis for an individual, and monitoring an individual, and , method for detecting the presence or absence of cervical cancer
MX339765B (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure.
WO2012094658A3 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
IN2014MN01759A (en)
MX2012003168A (en) Methods and composition for diagnosis and prognosis of renal injury and renal failure.
IN2014MN00949A (en)
BR112015021507A2 (en) methods and compositions for the diagnosis of preeclampsia
IN2014MN01760A (en)
WO2018085363A3 (en) Cd147 detection in diagnostic, prognostic and monitoring methods for multiple myeloma
WO2012103450A3 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure